A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

Jarrod J. Mousa(Florida State University), James E. Crowe(Vanderbilt University Medical Center), Pavlo Gilchuk(AstraZeneca (Japan)), Pranathi Matta(Vanderbilt University Medical Center), Nurgun Kose(Vanderbilt University Medical Center)
Nature Microbiology
January 30, 2017
10.1038/nmicrobiol.2016.271
Cited by 116

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Mxra8 is a receptor for multiple arthritogenic alphaviruses
|Nature|2018|455